How do vascular surgeons perceive atherosclerotic risk factor management?

Annals of Vascular Surgery

Volumn 14, Issue 6, 2000, Pages 652-658

  Kalman, Peter G ^a   Irvine, Jane ^a   Ritvo, Paul ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; COMPETENCE; CONTINUING EDUCATION; DIABETES MELLITUS; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; NUTRITION; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SMOKING; VASCULAR SURGERY;

EID: 0033651726     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169910116     Document Type: Article

References (27)

1. Epidemiology of peripheral vascular disease
2. Low rates of preventative practices in patients with peripheral vascular disease
3. Risk factor analysis
4. Lower extremity arterial disease and the aging process: A review
5. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley diabetes study
6. The peripheral vascular consequences of smoking
7. Intermittent claudication. A risk profile from The Framingham Heart Study
8. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease
9. The effect of smoking on the late patency of arterial reconstructions in the legs
10. The influence of smoking on the level of lower limb amputation
11. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
12. Sustained-release bupropion for smoking cessation
13. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UKPDS 33)
15. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 Years of follow-up in the Framingham Study
16. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease
17. Serum lipoproteins and hemostatic function in intermittent claudication
18. Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH)
19. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)
20. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis
21. Exercise therapy for claudication
22. Exercise training improves functional status in patients with peripheral arterial disease
23. Effect of daily muscular exercise in patients with intermittent claudication
24. Value of a supervised exercise program for the therapy of arterial claudication
25. The association of elevated plasma homocysteine with progression of symptomatic peripheral arterial disease
26. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease
27. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study